[Secondary effects of transfusions in hemophiliacs].
作者信息
Allain J P
出版信息
Rev Fr Transfus Immunohematol. 1979 Feb;22(1):77-81. doi: 10.1016/s0338-4535(79)80026-4.
PMID:493793
Abstract
摘要
相似文献
1
[Secondary effects of transfusions in hemophiliacs].
Rev Fr Transfus Immunohematol. 1979 Feb;22(1):77-81. doi: 10.1016/s0338-4535(79)80026-4.
2
Transfusion support for haemophiliacs.
Clin Haematol. 1984 Feb;13(1):99-117.
3
[Therapy-induced hepatitis risk in hemophilia patients].
Z Arztl Fortbild (Jena). 1983;77(19):807-10.
4
Jaundice and hepatitis B antigen-antibody in hemophilia.
Transfusion. 1974 May-Jun;14(3):203-11. doi: 10.1111/j.1537-2995.1974.tb04519.x.
5
Nonprogressive course of non-A, non-B chronic hepatitis in multitransfused hemophiliacs.
Blood. 1982 Sep;60(3):655-8.
6
Hemophiliacs with inhibitors: therapeutic options.
N Engl J Med. 1981 Sep 24;305(13):757-8. doi: 10.1056/NEJM198109243051308.
7
The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies.
Vox Sang. 2000;78(4):256-61.
8
[Viral hepatitis in hemophiliac patients treated with commercial concentrates of factors VIII and IX].
Med Clin (Barc). 1985 Apr 6;84(13):516-9.
9
[Acquired immunodeficiency syndrome and related syndromes in hemophiliacs: status throughout the world].
Rev Fr Transfus Immunohematol. 1984 Sep;27(4):493-6. doi: 10.1016/s0338-4535(84)80147-6.
10
Addition of hepatitis-B immunoglobulin to clotting factors.
Lancet. 1980 Sep 6;2(8193):537.
Zotero 插件